Litcius/Paper detail

Circulating tumor cells: mechanisms and clinical significance in colorectal cancer metastasis

Xuanyu Ren, Mei Song, Xianzhi Liu, Weiling He

2025Molecular Cancer15 citationsDOIOpen Access PDF

Abstract

Tumors are a major global health problem. As economic development and material standards increase, the incidence and mortality of digestive system tumors have shown an overall rising trend. Among them, colorectal cancer (CRC) is the third most common cancer and the second leading cause of cancer death worldwide. Despite advances in molecular biology and therapeutic strategies, tumor metastasis remains the main driver of cancer-related deaths (about 90%). Especially in CRC, the progression of metastasis greatly limits clinical intervention options. Circulating tumor cells (CTCs), a key mediator of hematogenous metastasis, have emerged as a key target for unravelling metastatic mechanisms and developing therapeutic strategies, and are gradually gaining prominence in tumor biology and precision medicine. Therefore, a comprehensive understanding of CTC-mediated mechanisms, especially in the invasion-metastasis cascade of CRC and other cancers of the digestive system, is crucial for early metastasis detection, prevention and identification of new therapeutic targets.

Topics & Concepts

Colorectal cancerMetastasisCirculating tumor cellClinical significanceCancerCancer researchOncologyMedicineMolecular oncologyMediatorCarcinogenesisBiologyIncidence (geometry)Cause of deathPrimary tumorInternal medicineDistant metastasisMouse model of colorectal and intestinal cancerTumor progressionCancer metastasisImmunologyTumor initiationIdentification (biology)Clinical PracticeTherapeutic approachBioinformaticsRectumPrecision medicineCancer cellCancer Cells and MetastasisMetastasis and carcinoma case studiesCancer Diagnosis and Treatment